Pharmaceutical & Healthcare | Kisaco Research

Pharmaceutical & Healthcare

Register for an event
Register for an event
Sponsor an Event
Sponsor an Event
Who’s Involved
Who’s Involved
Filter by:
 
14-15 Nov 2018
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
 
Personalised Nutrition Europe is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet, incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.Personalised Nutrition Europe draws on industry leaders who discuss how to integrate existing and new types of data around health and disease to reveal informative and actionable insights. The Summit will teach you how to better acquire, understand and use your data to forge the key partnerships in this industry. Key Takaways:How can I scale up my product?How can I measure the performance of my nutritional intervention?How can I better target the consumer by understanding motivation behind nutrition choices?How can I partner with retailers and industry leaders?How do I use my data to forge partnerships in industry?How can I target my consumer better and ensure they adhere to nutritional plans?How to identify and incorporate the best science into my business?How can I produce high quality data with low cost testing?How can I improve my business strategy to capitalise on growing interest in personalisation?What policy changes do I need to consider to protect my business?
 
29-30 Jan 2019
Washington DC, USA
The Phage Futures Congress will bring together peers from biotech companies and academia, along with experts from regulatory bodies, pharmaceutical companies and government institutions, to discuss how to actively progress clinical science and viable phage application routes to market. You will hear about:Regulatory guidance to achieve clinical data from Cara Fiore, FDAStrategies to access the market via the veterinary, personalized medicine and traditional pharmaceutical routesInsights into investment drivers for phage therapy from NIH and Boehringer IngelheimFacts on how to manufacture GMP phageApplications to overcome multi-drug resistance with combined approaches such as phage therapy and antibiotics "This congress has the potential to act as a catalyst to further cooperative and collaborative efforts to develop alternate Phage based approaches to the antibiotic crisis. In addition, the location in the Washington DC area will facilitate an opportunity for Government Agencies, responsible for public health, such as the NIH, FDA, USDA and DOD to participate and interact with educational research groups and biotechnology companies developing phage therapies and initiating clinical testing." - Carl Merril, Adaptive Phage Therapeutics
 
30-31 Jan 2019
London, United Kingdom
CAR-T cell therapy has shown unparalleled success in haematological malignancies, paving the way for the field of immuno-oncology. In 2017 two therapies achieved FDA approval in the USA, and following recent approval by the EMA, it is a landmark time for the industry. Despite the huge successes there are still a number of hurdles to overcome before CAR-T can be effective in mainstream oncology beyond haematological malignancies. The European CAR-T Congress’ mission is to address the opportunities and challenges that presently face the CAR-T field, to maximise the potential of this ground-breaking therapy.Sessions include:Solid tumour targeting: overcoming the tumour microenvironmentMulti-specific & dual targeting CARsProcess development, scalability & automationAllogeneic vs Autologous: the potential of off-the-shelf therapiesPatient access, implementation & regulatory challengesAdvances in gene engineeringSafety and toxicity
 
Join the first ever conference connecting human biotechs with the animal health industry. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
2-4 Apr 2019
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
Filter by:
 
26-27 Jun 2018
San Francisco, CA, USA
The Personalized Nutrition Innovation Summit is dedicated to the innovators & disruptors in nutrition. Bringing together industry leaders with emerging companies & start-ups to discuss the potential of this growing field on public health. Meet the start-ups redefining diet incorporating a wide range of analytics and technologies to provide insights into healthcare, and hear from global nutrition companies on how the technology revolution will impact the food industry & influence consumer trends.5 key benefits of attending:• Enabling collaboration through dedicated networking sessions• Hear from the disruptors like Habit• Gain insight from major nutrition companies like Kellogg to understand their drivers• Understand from STYR Labs about making better babies through personalized nutrition and AI• Recognize the major consumer trends reshaping nutritionFeaturing breakthrough technologies, including:• Microbiome analytics• Genomics• Biomarkers• Biosensors & wearables• AI & Big data• Retail & eCommerce
 
18-19 Jun 2018
Amsterdam, The Netherlands
Join the first ever conference series connecting human biotechs with the animal health industry. Following the event's hugely successful launch in Boston, USA, Human Biotech & Animal Health Business Partnering Summit is now coming to Europe. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
23 May 2018
Novotel London West, London, UK
The Microbiome Invest Congress 2018 is dedicated to showcasing the most innovative emerging companies and academics with commercially viable research that manipulates the microbiome. Active investors, and multi-national nutrition and pharmaceutical companies will also share their knowledge and perspectives on commercialisation and discuss the most cutting-edge products and research in the microbiome space.
 
8-9 May 2018
Boston, USA
The influence of the microbiome on human health & disease has been a growing area of interest in recent years, however until recently the impact of the microbiome on the initiation, progression & treatment of cancer was unknown. In recent months research has uncovered the potential of the microbiome to improve cancer therapies and to be a useful tool for patient stratification and diagnostics. With a better understanding of the oncobiome there is the potential to improve patient outcomes and increase the efficacy of existing therapies and drugs.
 
20-22 Mar 2018
Boston, USA
The CAR-T Congress gathers thought leaders from biotech, big pharma, academia and investment to address the challenges and opportunities of CAR-T therapies in both liquid and solid tumors. Discussing the potential of CARs in alternative cell types, mechanisms behind toxicity and tumor targeting, this event will provide an in depth view into this expansive area.
 
Join the first ever conference connecting human biotechs with the animal health industry. Traditionally, innovation in veterinary health has come from parent human pharmaceutical R&D pipelines. Within an increasingly independent and mature animal health industry, new routes to innovation are being established. There are a multitude of exceptional technologies in the human health field that could be used in animal health, but currently there is limited contact between the two areas – this summit aims to connect the two industries.
 
The Artificial Intelligence: Transforming Pharma Congress will discuss AI's potential for more efficiently discovering medical trends and efficacious therapeutics and also for streamlining the development phase. We'll be sharing case studies and analysis into current AI partnerships and collaborations.
 
30-31 Jan 2018
Berlin, Germany
CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematological malignancies…is CAR-T therapy what we’ve been waiting for?Join 18+ thought-leaders from biotech, big pharma, academia and the wider service community on 30th – 31st January 2018 at Europe’s first congress dedicated to addressing the challenges and opportunities of CAR-T therapies.Hear first-hand results from unpublished human and clinical studiesExplore the challenges of the tumour microenvironmentUnderstand how to implement a combined approach to cell therapyDiscover safety switch improvement strategiesNetwork with 100+ attendees to share knowledge and understand the commercial opportunities of CAR-TWith a 50:50 split of academia to industry, build relationships whilst being updated by 20+ amazing speakers from University Hospital of Cologne, Catapult, Cellectis and more on all of the latest developments in this exciting field. Get involved today.
 
24-25 Jan 2018
Berlin, Germany
The 3D Cell Models Congress 2018 will present the latest developments and innovation in three-dimensional cell models including organoids, spheroids, and organ-on-a-chip, as well as bioprinting technologies.
 
27-29 Nov 2017
London, UK
The Annual European Microbiome Congress by Kisaco Research has become a trusted learning and networking platform and a true business community for microbiologists, clinicians regulatory and industry executives who require insight into the latest in microbiome research, clinical trials and collaborative partnerships.
 
18-19 Oct 2017
London, UK
With the increase in the number of cell and gene therapies being developed and coming to market globally and the potential to revolutionise the treatment of disease, this summit will discuss strategies for pricing and contracting cell or gene therapies that will allow payers to fund these innovative and significantly beneficial therapies to result in rapid patient access.
 
18-19 Oct 2017
Grand Hyatt, Beijing, PRC
Animal Health Innovation Asia is the premier B2B conference showcasing innovative technologies within the livestock, aquaculture and companion animal health markets. Last year, over 160 senior-level executives and influencers joined us to engage with the industry and discuss financial investment, M&A and market access into Asia. Our 2017 event in Beijing had a special focus on China, with ten strategic partners from the region forming our Company Showcase - a chance for global companies to find new business partners from within China.
 
27-28 Sep 2017
London, UK
The Aquaculture Innovation Summit is a new conference, as part of the Animal Health Innovation series, which focuses on showcasing and supporting innovation and sustainability initiatives in three key areas of aquaculture: farm management, nutrition and health.

Sponsorship Opportunities

At Kisaco Research we bring our clients both intensively researched conference programmes and the most influential networks. Kisaco Research genuinely helps its clients set and reset their business destinations and chart their own courses.

Benefits of Attending our Events

Meet industry peers that will help build a career-changing network for life.

MEET

industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes - ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

LEARN

from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

NOTE

down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest from the mistakes of your peers as much as their successes - ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

INVEST

both in your company growth and your own personal development by signing up to one of our events and get started.